

LAVALTRIE – September 15, 2025 – Vetoquinol is proud to announce the availability of Simplera®, a veterinary-prescribed ear solution for dogs, now available across Canada.
Simplera® is applied in-clinic by a veterinarian in a single administration. It contains a combination of three active ingredients: mometasone furoate, terbinafine hydrochloride, and florfenicol. This product is available by prescription only and is intended for use under the direction of a licensed veterinarian.
Manufactured in Canada - domestic and imported content, Simplera® reflects Vetoquinol’s ongoing commitment to supporting veterinarians in their daily practice.
"We are excited to bring Simplera® to Canadian veterinarians and their clients," said Alexandre Fournier, Country Manager at Vetoquinol Canada. "This launch reinforces our commitment to supporting veterinary professionals with practical, effective solutions—backed by both science and service."
Latest news

Vetoquinol Give Back Initiative
May 2025

Vetoquinol Canada Announces the Launch of Flexadin® Essential, an Evolution of the Flexadin® Line
October 2024

32nd World Biannual Conference on Buiatrics: Concrete Advances Shaping the Future of Cattle Farming
August 2024